These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1320812)

  • 21. Plasma concentrations of enrofloxacin and its active metabolite ciprofloxacin in dogs following single oral administration of enrofloxacin at 7.5, 10, or 20 mg/kg.
    Boothe DM; Boeckh A; Boothe HW; Wilkie S; Jones S
    Vet Ther; 2002; 3(4):409-19. PubMed ID: 12584678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of the new fluoroquinolone balofloxacin in mice, rats, and dogs.
    Nakagawa T; Ishigai M; Kato M; Hayakawa N; Kinoshita H; Okutomi T; Ohkubo K; Okazaki A
    Arzneimittelforschung; 1995 Jun; 45(6):719-22. PubMed ID: 7646579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enrofloxacin: a new antimicrobial agent.
    Schroder J
    J S Afr Vet Assoc; 1989 Jun; 60(2):122-4. PubMed ID: 2691696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of enrofloxacin and danofloxacin in plasma, inflammatory exudate, and bronchial secretions of calves following subcutaneous administration.
    McKellar Q; Gibson I; Monteiro A; Bregante M
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1988-92. PubMed ID: 10428924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of endotoxin and dexamethasone on enrofloxacin pharmacokinetic parameters in swine.
    Post LO; Farrell DE; Cope CV; Baker JD; Myers MJ
    J Pharmacol Exp Ther; 2003 Feb; 304(2):889-95. PubMed ID: 12538847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-bioequivalence of various trademarks of enrofloxacin and Baytril in cows.
    Sumano LH; Ocampo CL; Gutiérrez OL
    Dtsch Tierarztl Wochenschr; 2001 Jul; 108(7):311-4. PubMed ID: 11505850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and lung tissue concentrations of tulathromycin in swine.
    Benchaoui HA; Nowakowski M; Sherington J; Rowan TG; Sunderland SJ
    J Vet Pharmacol Ther; 2004 Aug; 27(4):203-10. PubMed ID: 15305848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pharmacokinetic behaviour of marbofloxacin in Eurasian buzzards (Buteo buteo) after intraosseous administration.
    Garcia-Montijano M; Waxman S; Lucas JJ; Luaces I; Zalba J; González F; Andrés MI; Rodríguez C
    Vet J; 2006 May; 171(3):551-5. PubMed ID: 16624724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic-pharmacodynamic integration of danofloxacin in the calf.
    Shojaee Aliabadi F; Lees P
    Res Vet Sci; 2003 Jun; 74(3):247-59. PubMed ID: 12726744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum concentrations and pharmacokinetics of enrofloxacin after intravenous and intragastric administration to mares.
    Haines GR; Brown MP; Gronwall RR; Merritt KA
    Can J Vet Res; 2000 Jul; 64(3):171-7. PubMed ID: 10935883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetic disposition of temafloxacin and ciprofloxacin in a murine model of pneumococcal pneumonia. Relevance for drug efficacy.
    Vallée E; Azoulay-Dupuis E; Bauchet J; Pocidalo JJ
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1203-8. PubMed ID: 1326627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of enrofloxacin given by the oral, intravenous and intramuscular routes in broiler chickens.
    Bugyei K; Black WD; McEwen S
    Can J Vet Res; 1999 Jul; 63(3):193-200. PubMed ID: 10480461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of pharmacokinetics of danofloxacin and enrofloxacin in calves challenged with Mannheimia haemolytica.
    TerHune TN; Skogerboe TL; Shostrom VK; Weigel DJ
    Am J Vet Res; 2005 Feb; 66(2):342-9. PubMed ID: 15757137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and tissue disposition of danofloxacin in sheep.
    McKellar QA; Gibson IF; McCormack RZ
    Biopharm Drug Dispos; 1998 Mar; 19(2):123-9. PubMed ID: 9533113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and penetration of danofloxacin into the gastrointestinal tract in healthy and in Salmonella typhimurium infected pigs.
    Lindecrona RH; Friis C; Nielsen JP
    Res Vet Sci; 2000 Jun; 68(3):211-6. PubMed ID: 10877965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors involved in the choice of routes of administration of antimicrobial drugs.
    Baggot JD
    J Am Vet Med Assoc; 1984 Nov; 185(10):1076-82. PubMed ID: 6392233
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in goats given enrofloxacin alone and in combination with probenecid.
    Rao GS; Ramesh S; Ahmad AH; Tripathi HC; Sharma LD; Malik JK
    Vet J; 2002 Jan; 163(1):85-93. PubMed ID: 11749141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pharmacokinetic study of E-4441, a new quinolone, in the rat, mouse and cynomolgus monkey.
    Martinez L; Basi N; Dordal A; Roser R; Sagarra R
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():352-6. PubMed ID: 1668199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and penetration of danofloxacin from the blood into the milk of cows.
    Shem-Tov M; Rav-Hon O; Ziv G; Lavi E; Glickman A; Saran A
    J Vet Pharmacol Ther; 1998 Jun; 21(3):209-13. PubMed ID: 9673962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of danofloxacin and N-desmethyldanofloxacin in adult horses and their concentration in synovial fluid.
    Lopez BS; Giguère S; Berghaus LJ; Mullins MA; Davis JL
    J Vet Pharmacol Ther; 2015 Apr; 38(2):123-9. PubMed ID: 25224604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.